(Q51123196)

English

Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

scientific article published on 15 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

focal segmental glomerulosclerosis

1 reference

based on heuristic

inferred from title

object named as

Divya Bhatia

4

0 references

author name string

Aditi Sinha

1

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Jaya Bajpai

2

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Savita Saini

3

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Aarti Gupta

5

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Mamta Puraswani

6

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Amit K Dinda

7

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Sanjay K Agarwal

8

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Shailaja Sopory

9

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Ravindra M Pandey

10

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Pankaj Hari

11

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Arvind Bagga

12

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

language of work or name

0 references

publication date

15 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Kidney International

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

85

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

3

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

649-658

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

https://scigraph.springernature.com/pub.10.1038/ki.2013.546

0 references

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating mediators of focal segmental glomerulosclerosis: soluble urokinase plasminogen activator receptor in context

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating suPAR in two cohorts of primary FSGS.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of kidney barrier function by the urokinase receptor.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum-soluble urokinase receptor concentration in primary FSGS

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Urine suPAR Levels Compared with Plasma suPAR Levels as Predictors of Post-consultation Mortality Risk Among Individuals Assumed to be TB-negative: A Prospective Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibroblast growth factor 23, hepatocyte growth factor, interleukin-6, high-sensitivity C-reactive protein and soluble urokinase plasminogen activator receptor. Inflammation markers in chronic haemodialysis patients?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble urokinase plasminogen activator receptor, C-reactive protein and triglyceride are associated with heart rate variability in non-diabetic Danes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

New equations to estimate GFR in children with CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistics and ethics in medical research: III How large a sample?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.546

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/KI.2013.546

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/24429405

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51123196&oldid=1456733404"